IL116525A0 - Piperazinedione derivatives their preparation and use - Google Patents

Piperazinedione derivatives their preparation and use

Info

Publication number
IL116525A0
IL116525A0 IL11652595A IL11652595A IL116525A0 IL 116525 A0 IL116525 A0 IL 116525A0 IL 11652595 A IL11652595 A IL 11652595A IL 11652595 A IL11652595 A IL 11652595A IL 116525 A0 IL116525 A0 IL 116525A0
Authority
IL
Israel
Prior art keywords
preparation
piperazinedione derivatives
piperazinedione
derivatives
Prior art date
Application number
IL11652595A
Other languages
English (en)
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Priority to TW084113836A priority Critical patent/TW358094B/zh
Publication of IL116525A0 publication Critical patent/IL116525A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11652595A 1994-12-23 1995-12-22 Piperazinedione derivatives their preparation and use IL116525A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW084113836A TW358094B (en) 1994-12-23 1995-12-23 Piperazinedione derivatives, their preparation and their use as moduators of multi-drug resistance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9426224.3A GB9426224D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
IL116525A0 true IL116525A0 (en) 1996-03-31

Family

ID=10766589

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11652595A IL116525A0 (en) 1994-12-23 1995-12-22 Piperazinedione derivatives their preparation and use

Country Status (19)

Country Link
EP (1) EP0799222A1 (zh)
JP (1) JPH10511384A (zh)
CN (1) CN1175253A (zh)
AU (1) AU698828B2 (zh)
BG (1) BG101602A (zh)
BR (1) BR9510410A (zh)
CA (1) CA2207500A1 (zh)
CZ (1) CZ190097A3 (zh)
FI (1) FI972660A (zh)
GB (1) GB9426224D0 (zh)
HU (1) HUT77943A (zh)
IL (1) IL116525A0 (zh)
NO (1) NO972937L (zh)
NZ (1) NZ297847A (zh)
PL (1) PL320916A1 (zh)
SK (1) SK83697A3 (zh)
TW (1) TW358094B (zh)
WO (1) WO1996020190A1 (zh)
ZA (1) ZA9510909B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA979329B (en) * 1996-10-18 1999-04-19 Xenova Ltd Pharmaceutical compounds
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
WO2000021951A1 (en) 1998-10-08 2000-04-20 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
EP1264831A4 (en) * 2000-01-18 2005-11-23 Nereus Pharmaceuticals Inc Cell division inhibitors and a method for fixing the same
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
EP1529044B1 (en) 2002-08-02 2007-10-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
US10076518B2 (en) 2015-03-06 2018-09-18 Beyondspring Pharmaceuticals, Inc. Method of treating a brain tumor
CA2978567A1 (en) 2015-03-06 2016-09-15 Beyondspring Pharmaceuticals, Inc. Method of treating cancer associated with a ras mutation using plinabulin
EP3334726B1 (en) 2015-07-13 2022-03-16 Beyondspring Pharmaceuticals, Inc. Plinabulin compositions
US10912748B2 (en) 2016-02-08 2021-02-09 Beyondspring Pharmaceuticals, Inc. Compositions containing tucaresol or its analogs
JP7025416B2 (ja) 2016-06-06 2022-02-24 ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド 好中球減少症を低減させるための組成物および方法
US11633393B2 (en) 2017-01-06 2023-04-25 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
WO2018144764A1 (en) 2017-02-01 2018-08-09 Beyondspring Pharmaceuticals, Inc. Method of reducing neutropenia
WO2019147615A1 (en) 2018-01-24 2019-08-01 Beyondspring Pharmaceuticals, Inc. Composition and method for reducing thrombocytopenia via the administration of plinabulin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2718830B2 (ja) * 1992-07-10 1998-02-25 ラボラトワール、グラクソ、ソシエテ、アノニム アニリド誘導体
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
NO972937D0 (no) 1997-06-23
TW358094B (en) 1999-05-11
NZ297847A (en) 1999-04-29
PL320916A1 (en) 1997-11-10
BG101602A (en) 1998-02-27
WO1996020190A1 (en) 1996-07-04
SK83697A3 (en) 1998-05-06
BR9510410A (pt) 1999-09-08
HUT77943A (hu) 1998-12-28
AU698828B2 (en) 1998-11-05
CZ190097A3 (cs) 1998-01-14
CA2207500A1 (en) 1996-07-04
NO972937L (no) 1997-06-23
ZA9510909B (en) 1996-08-30
FI972660A (fi) 1997-08-22
AU4310096A (en) 1996-07-19
GB9426224D0 (en) 1995-02-22
CN1175253A (zh) 1998-03-04
EP0799222A1 (en) 1997-10-08
FI972660A0 (fi) 1997-06-19
JPH10511384A (ja) 1998-11-04

Similar Documents

Publication Publication Date Title
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
IL115717A0 (en) Heterocyclic compounds and their preparation and use
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
NZ281404A (en) Tricyclic pyrimidine derivatives and medicaments
IL122216A0 (en) Dolastatin derivatives their preparation and use
IL116525A0 (en) Piperazinedione derivatives their preparation and use
IL116139A0 (en) Pyrrole derivatives their preparation and use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
ZA979175B (en) Novel piperidineketocarboxylic acid derivatives their preparation and use
GB2286393B (en) Piperazinedione derivatives and pharmaceutical uses thereof
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
NZ332309A (en) Alkylamino-benzothiazole and -benzoxazole derivatives and medicaments
ZA973097B (en) Novel aspire-hydroxy acid derivatives their preparation and use
ZA9511046B (en) 3-Phenylisoquinol-1(2H)-one derivatives their preparation and their therapeutic application
GB9617322D0 (en) Triazine derivatives and their use
ZA952410B (en) Substituted heterocyclic carboxamioesters their preparation and their use as pharmaceuticals
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
IL114490A0 (en) Heterocyclic compounds their preparation and their use
IL123535A0 (en) Benzoxazindione derivatives and their use
IL122686A0 (en) Benzylhydroxylamines their preparation and use